Current filters:


Popular Filters

8020 to 8044 of 8831 results

Generic erosion will reduce BPH/male urinary tract drug market to $4 billion in 2010


The market for therapies that treat benign prostatic hyperplasia (BPH) and associated lower urinary tract…

Gastro-intestinalsGenericsGlobalMarkets & MarketingPharmaceutical

Pharma majors no longer see sales as the only measure of success, says Kantar Health


Over two-thirds of respondents from leading companies in the pharmaceutical sector think that customer…

GlobalMarkets & MarketingPharmaceutical

Lupin acquires Japanese drugmaker I’rom Pharma


Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I’rom…

Asia-PacificGenericsI'rom PharmaceuticalLupinMergers & Acquisitions

Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe


Following a positive opinion from an advisory committee in the summer (The Pharma Letter July 23), the…

EuropePfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

AstraZeneca’s thyroid cancer drug Caprelsa gets positive CHMP opinion


Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that its Marketing Authorization…


GlaxoSmithKline’s albiglutide fails to show superiority over Novo Nordisk’s Victoza


UK pharma giant GlaxoSmithKline (LSE: GSK) released disappointing top-line results from the first of…

albiglutideDiabetesGlaxoSmithKlineNovo NordiskPharmaceuticalResearchVictoza

Newron says it has received interest in safinamide, rejected by Merck Serono


Following the announcement of Switzerland-based Newron Pharmaceuticals (SIX: NWRN) regaining the global…

LicensingNeurologicalNewron PharmaPharmaceuticalsafinamide

EU Commission unveils 12 concrete actions against antimicrobial resistance for the next five years


With about 25,000 patients dying per year in the European Union from infections caused by drug resistant…

Antibiotics and Infectious diseasesEuropePharmaceuticalRegulationResearch

Stakeholders deliberate accessibility, debate whether pricing hinders access to health care in India


To address the burgeoning concern about the need to ensure health care access in India, ASSOCHAM organized…


Brand drug 'Co-pay Coupons' undermine generics, raise health costs by $1.1 billion in US state of Michigan


The proliferation of brand drug "co-pay coupon" promotions, which lure insured consumers from generics…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Hormone that controls iron levels may be target for atherosclerosis treatment, researchers find


Researchers at Emory University School of Medicine, USA, have identified hepcidin, a hormone that regulates…


UK’s NICE rejects Eisai’s Halaven for advanced breast cancer


In a second negative from the UK’s National Institute for Health and Clinical Excellence, in final…


Japan generics market: Boom or Bust? by P Reed Maurer


Japan has the lowest generic utilization rate of developed markets. Thus, as you might expect, Japan…

Asia-PacificGenericsMarkets & MarketingPricing

Indian vaccine market targets $4.6 billion revenue by 2017, up from current $900 million


The Indian vaccine market is currently estimated to be worth around $900 million and targets $4.6 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearchVaccines

Boehringer Ingelheim invests over $350 million in 2011 US expansion projects


Privately-held German drug major Boehringer Ingelheim says that it has made more than $350 million worth…

Boehringer IngelheimFinancialNorth AmericaPharmaceuticalResearch

Health organizations in USA will act despite political and economic uncertainty, PwC survey finds


In its annual report on the top health industry issues for the year ahead, PwC's Health Research Institute…

HealthcareNorth AmericaPharmaceuticalRegulationResearch

Premier report “inaccurate in reporting drug price profit margins of small distributors” in USA, says Pharma Commerce


A report by Premier healthcare alliance incorrectly calculated the percent markup charged by small distributors…

North AmericaPharmaceuticalPricing

Stem cell research market to 2017 has strong pipeline, but high unmet needs in chronic diseases


Strategic partnerships between pharmaceutical companies and stem cell research companies have been given…


Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida


Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

8020 to 8044 of 8831 results

Back to top